We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · July 05, 2020

Effects of Empagliflozin Treatment on Glycerol-Derived Hepatic Gluconeogenesis in Adults With Obesity

Obesity 

 

Additional Info

Obesity 
Effects of Empagliflozin Treatment on Glycerol-Derived Hepatic Gluconeogenesis in Adults with Obesity: A Randomized Clinical Trial
Obesity 2020 Jul 01;28(7)1254-1262, IJ Neeland, N de Albuquerque Rocha, C Hughes, CR Ayers, CR Malloy, ES Jin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading